40 related articles for article (PubMed ID: 38679630)
1. Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study.
Zhang X; Zhu X; Zhong J; Zhao Y; Zhang X; Zhang W; Ye F; Yang C; Xue J; Xiong R; Wang J; Shen S; Pan Y; Li D; Song T; Bi X; Sun H; Xiang B; Gu S; Wen T; Lu S; Chen Y; Yin T; Liu L; Kuang M; Xu L; Li D; Cai J
Sci Rep; 2024 Apr; 14(1):9745. PubMed ID: 38679630
[TBL] [Abstract][Full Text] [Related]
2. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
[TBL] [Abstract][Full Text] [Related]
3. The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study.
Mao K; Yan Y; Zhang J; Wang J; Wang R; Ling X; Liu Y; Lau WY; Jiang S; Liu J; Xiao Z
Cancer Med; 2018 Sep; 7(9):4475-4484. PubMed ID: 30117307
[TBL] [Abstract][Full Text] [Related]
4. Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis.
Xia F; Wu L; Lau WY; Li G; Huan H; Qian C; Ma K; Bie P
PLoS One; 2014; 9(4):e95889. PubMed ID: 24760012
[TBL] [Abstract][Full Text] [Related]
5. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
6. Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion.
Lee D; Lee HC; An J; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
Clin Mol Hepatol; 2018 Jun; 24(2):144-150. PubMed ID: 29665630
[TBL] [Abstract][Full Text] [Related]
7. Impact of tumor burden score on timing and patterns of recurrence after curative-intent resection of hepatocellular carcinoma.
Moazzam Z; Lima HA; Alaimo L; Endo Y; Shaikh CF; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Surgery; 2022 Nov; 172(5):1448-1455. PubMed ID: 36031442
[TBL] [Abstract][Full Text] [Related]
8. A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion.
Kudo M
Liver Cancer; 2021 Nov; 10(6):539-544. PubMed ID: 34950177
[No Abstract] [Full Text] [Related]
9. STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery.
Mathew G; Agha R; Albrecht J; Goel P; Mukherjee I; Pai P; D'Cruz AK; Nixon IJ; Roberto K; Enam SA; Basu S; Muensterer OJ; Giordano S; Pagano D; Machado-Aranda D; Bradley PJ; Bashashati M; Thoma A; Afifi RY; Johnston M; Challacombe B; Ngu JC; Chalkoo M; Raveendran K; Hoffman JR; Kirshtein B; Lau WY; Thorat MA; Miguel D; Beamish AJ; Roy G; Healy D; Ather HM; Raja SG; Mei Z; Manning TG; Kasivisvanathan V; Rivas JG; Coppola R; Ekser B; Karanth VL; Kadioglu H; Valmasoni M; Noureldin A;
Int J Surg; 2021 Dec; 96():106165. PubMed ID: 34774726
[TBL] [Abstract][Full Text] [Related]
10. Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy.
Yang X; Xu H; Zuo B; Yang X; Bian J; Long J; Wang D; Zhang J; Ning C; Wang Y; Xun Z; Wang Y; Lu X; Mao Y; Sang X; Zhao H
Hepatobiliary Surg Nutr; 2021 Aug; 10(4):434-442. PubMed ID: 34430522
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma.
Zhang W; Zhang B; Chen XP
Front Med; 2021 Apr; 15(2):155-169. PubMed ID: 33754281
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).
Zhou J; Sun H; Wang Z; Cong W; Wang J; Zeng M; Zhou W; Bie P; Liu L; Wen T; Han G; Wang M; Liu R; Lu L; Ren Z; Chen M; Zeng Z; Liang P; Liang C; Chen M; Yan F; Wang W; Ji Y; Yun J; Cai D; Chen Y; Cheng W; Cheng S; Dai C; Guo W; Hua B; Huang X; Jia W; Li Y; Li Y; Liang J; Liu T; Lv G; Mao Y; Peng T; Ren W; Shi H; Shi G; Tao K; Wang W; Wang X; Wang Z; Xiang B; Xing B; Xu J; Yang J; Yang J; Yang Y; Yang Y; Ye S; Yin Z; Zhang B; Zhang B; Zhang L; Zhang S; Zhang T; Zhao Y; Zheng H; Zhu J; Zhu K; Liu R; Shi Y; Xiao Y; Dai Z; Teng G; Cai J; Wang W; Cai X; Li Q; Shen F; Qin S; Dong J; Fan J
Liver Cancer; 2020 Dec; 9(6):682-720. PubMed ID: 33442540
[TBL] [Abstract][Full Text] [Related]
13. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights.
Xie DY; Ren ZG; Zhou J; Fan J; Gao Q
Hepatobiliary Surg Nutr; 2020 Aug; 9(4):452-463. PubMed ID: 32832496
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
